Multi-Organ-on-a-Chip Technologies: Towards a paradigm shift in drug development
TissUse the speaker lineup for Drug Discovery 2017 in March.
- (1888PressRelease) December 20, 2016 - SMi has confirmed that TissUse, leading pioneers of the Multi-Organ-Chip technology, will be joining the expert speaker lineup for the inaugural conference on Drug Discovery. The event will be launched on the 27th and 28th of April 2017 in London.
TissUse's proprietary multi-organ-chip technology platform closely emulates/simulates human biology to achieve uniquely lifelike environments. Connected organs and close physiological context allowremarkably close resemblance to in vivo conditions. This has benefited the drug development process, with current in vitro and animal modelling tests failing to emulate physiological organ complexity within the human body.
Head of Business Development, Reyk Horland, will be leading a spotlight session on multi-organ-chip technologies and its potential impact on drug discovery.
A few key points of the presentation include:
* "Human-on-a-chip" technology allows us to closely study organoid interaction
* Allows more representative drug toxicity and efficacy screening.
o Could this be the end of preclinical trials as we know them?
* Closing the gap between in vivo and in vitro
o The importance of highly physiologically relevant cultures and microenvironments.
Reyk will be speaking on Day 2 of the conference and joins lead decision-makers and industry innovators from Sanofi, Takeda, AstraZeneca, Merck Serono, AbbVie, GSK, Johnson & Johnson, UCB Pharma, Eli Lilly and more. A full list of speakers can be found on www.drug-discovery.co.uk/1888.
SMi's Drug Discovery conference aims to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges.
The event will also feature two post-conference workshops on new approaches in lead generation and applications of physicochemical and biomimetic properties in early drug discovery.
For more details about the conference and registration information, visit www.drug-discovery.co.uk/1888.
DRUG DISCOVERY
27 - 28 MARCH 2017
Holiday Inn Kensington Forum
www.drug-design.co.uk/1888
Contact Information:
For sponsorship and exhibition queries please contact Alia Malick at amalick ( @ ) smi-online dot co dot uk dot For delegate queries please contact Fateja Begum at fbegum ( @ ) smi-online dot co dot uk dot For media queries please contact Honey de Gracia at hdegracia ( @ ) smi-online dot co dot uk dot
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam